Cardinal Health Inc
CAH (NYSE)
Cardinal Health Inc (CAH) stands out as a top-performing healthcare stock, boasting an impressive one-year return of 75.22% and a five-year return of 325.07%. With a dividend yield of 0.90%, it represents an attractive option for investors seeking reliable income from a leading distributor of pharmaceuticals and medical products in the U.S. Analysts maintain a consensus rating of Buy, with a median price target of $255.00, indicating strong potential for future growth despite recent financial challenges.
Pros:
- High one-year return
- Leading distributor in healthcare
Cons:
- Financial strain and operational pressures
- Dependence on pharmaceutical distribution
Cardinal Health Inc (CAH) may be a suitable investment for those seeking exposure to the healthcare sector with a strong track record of returns and potential for future growth. Its relatively modest dividend yield combined with significant capital appreciation makes it appealing for growth-focused investors, while its status as a leading distributor of pharmaceuticals and medical products offers stability in a vital industry.